Prosecution Insights
Last updated: April 19, 2026

Obsidian Therapeutics Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18501621 ADMINISTRATION OF TUMOR INFILTRATING LYMPHOCYTES WITH MEMBRANE BOUND INTERLEUKIN 15 TO TREAT CANCER HILL, KEVIN KAI 1638 Non-Final OA Nov 03, 2023
17791091 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF TRANSCRIPTION WILSON, MICHAEL C 1638 Non-Final OA Jul 06, 2022
17436892 CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION EDWARDS, JESSICA FAYE 1657 Final Rejection Sep 07, 2021

Managing Obsidian Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month